Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Nextar Chempharma Solutions Ltd. logo — Contract services; One-Stop-Shop drug development; CMC; Brai...

Nextar Chempharma Solutions Ltd.

Contract services; One-Stop-Shop drug development; CMC; Brain-targeted Liposomes; PEGylated liposomes; Nanoparticles;

Founded 2007 Israel Israel 27 employees

General Information

Company Name Nextar Chempharma Solutions Ltd.
Founded Year 2007
Location Israel Israel +1
Employees 27
Social

Get notified when Nextar Chempharma Solutions Ltd. moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Nextar Chempharma Solutions Ltd.

Nextar Chempharma Solutions Ltd. is an Israeli biotechnology company that develops and manufactures innovative pharmaceuticals and medical devices. The company has helped bring over 180 products to market, both as a contract development and manufacturing organization (CDMO) and for its own portfolio. Nextar has manufacturing capabilities for small-scale sterile and non-sterile products, and its facilities are fully certified and some of the drug products we helped to develop are commercialized globally. Nextar is also developing a proprietary Brain-Transported Liposomes (BTLs) platform, which can deliver generic and innovative drugs across the blood-brain barrier (BBB) into the brain. This platform has the potential to revolutionize the treatment of brain diseases, such as brain cancer and Parkinson's. Nextar's first product based on the BTLs platform is currently in development for the treatment of glioblastoma. In other words, Nextar is a cutting-edge biotechnology company that is developing innovative new treatments for brain diseases. The company's BTLs platform has the potential to revolutionize the way we treat brain-related diseases.

No funding data available for Nextar Chempharma Solutions Ltd. yet.

Get notified when Nextar Chempharma Solutions Ltd. raises funding

Nextar Chempharma Solutions Ltd. Alternatives & Competitors

Nextar Chempharma Solutions Ltd. vs
BBB Therapeutics
BBB Therapeutics The Netherlands

Combines existing drugs with it's proprietary for enhanced drug delivery across the blood-brain barr...

Unknown
21 employees
Biopharma, Biotechnology
Nextar Chempharma Solutions Ltd. vs
Orca Bio
Orca Bio United States

Transforming allogeneic cell therapy for patients with cancer and autoimmune diseases.

Series D
327 employees
Health Care, Pharmaceutical
Nextar Chempharma Solutions Ltd. vs
Sulfateq B.V.
Sulfateq B.V.

Empowering Health

7 employees
Biotechnology, Health Care

FAQ About Nextar Chempharma Solutions Ltd.

Contract services; One-Stop-Shop drug development; CMC; Brain-targeted Liposomes; PEGylated liposomes; Nanoparticles;
Nextar Chempharma Solutions Ltd. was founded in 2007.
Nextar Chempharma Solutions Ltd. is headquartered in Israel.
Nextar Chempharma Solutions Ltd. has approximately 27 employees.
Top alternatives and competitors to Nextar Chempharma Solutions Ltd. include BBB Therapeutics, Orca Bio, Sulfateq B.V., Visterra Inc., Benta Pharma Industries- BPI. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Nextar Chempharma Solutions Ltd. and BBB Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Nextar Chempharma Solutions Ltd. and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy